# OpenAI将收购Orchestra Bio

> OpenAI称，将收购Orchestra Bio，为药物研发引入AI工具。

Oossa · 2026-10-20 · https://oossa.com/zh/openai-to-acquire-orchestra-bio

OpenAI宣布将收购Orchestra Bio。这笔交易旨在将AI引入生命科学研究实验室。OpenAI表示，此举将帮助生物制药团队加快药物开发，并研发新疗法。交易的财务条款尚未披露。

## 事实

- OpenAI于2026年10月20日宣布这项收购。
- 被收购方Orchestra Bio是一家专注于生命科学AI的初创公司。

## 为什么重要

生物技术公司可以利用OpenAI的模型，缩短药物候选物的测试时间。

## 来源与参考

1. [OpenAI acquires Orchestra Bio](https://openai.com/index/openai-to-acquire-orchestra-bio) – OpenAI, 2026-10-20
2. [OpenAI acquires Orchestra Bio to bring AI agents into drug development](https://siliconangle.com/2026/10/20/openai-acquires-orchestra-bio-to-bring-ai-agents-into-drug-development/) – SiliconANGLE, 2026-10-20
3. [OpenAI acquires startup Orchestra Bio⁠ to beef up its biotech business](https://techcrunch.com/2026/10/20/openai-acquires-startup-orchestra-bio%e2%81%a0-to-beef-up-its-biotech-business/) – TechCrunch, 2026-10-20
4. [OpenAI acquires Orchestra Bio to build AI agents that speed up drug development](https://the-decoder.com/openai-acquires-orchestra-bio-to-build-ai-agents-that-speed-up-drug-development/) – The Decoder, 2026-10-21
5. [OpenAI Invests in Startup That Uses Brain Implants to Detect Cancer](https://www.wired.com/story/openai-startup-brain-implants-detect-cancer/) – Wired, 2026-10-21

最后更新: 2026-10-21